(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -3.18%34.39B | 1.91%24.54B | 12.93%11.77B | 13.08%47.08B | 15.87%35.51B | 13.03%24.08B | 4.13%10.43B | -37.99%41.63B | -43.69%30.65B | -49.82%21.3B |
Operating income | -3.18%34.39B | 1.91%24.54B | 12.93%11.77B | 13.08%47.08B | 15.87%35.51B | 13.03%24.08B | 4.13%10.43B | -37.99%41.63B | -43.69%30.65B | -49.82%21.3B |
Cost of sales | ---- | -1.32%-17.59B | ---- | -4.81%-34.11B | ---- | -2.88%-17.36B | ---- | 36.54%-32.54B | ---- | 47.00%-16.87B |
Operating expenses | 4.00%-24.63B | -1.32%-17.59B | -9.46%-8.4B | -4.81%-34.11B | -5.93%-25.66B | -2.88%-17.36B | 4.11%-7.67B | 36.54%-32.54B | 41.17%-24.22B | 47.00%-16.87B |
Gross profit | -1.03%9.76B | 3.42%6.95B | 22.60%3.37B | 42.67%12.97B | 53.36%9.86B | 51.74%6.72B | 36.94%2.75B | -42.67%9.09B | -51.51%6.43B | -58.30%4.43B |
Selling expenses | -7.58%-2.77B | -12.21%-1.9B | -28.00%-866.39M | -34.99%-3.56B | -36.43%-2.57B | -46.63%-1.7B | -35.78%-676.84M | 24.13%-2.64B | 32.99%-1.88B | 43.86%-1.16B |
Administrative expenses | -35.00%-1.71B | -28.97%-1.34B | -40.51%-527.17M | 5.25%-2.27B | -14.26%-1.27B | -26.86%-1.04B | -11.67%-375.18M | -21.03%-2.4B | 10.14%-1.11B | 21.85%-819M |
Research and development expenses | 27.66%-1.86B | 17.60%-1.31B | -3.10%-665.44M | -37.26%-3.44B | -43.42%-2.57B | -41.27%-1.59B | -48.70%-645.46M | 35.14%-2.51B | 39.06%-1.79B | 44.04%-1.12B |
Profit from asset sales | 3,539.74%663.68M | ---- | -106.57%-8.85M | ---- | -531.59%-19.29M | ---- | -229.82%-4.29M | ---- | -93.66%4.47M | ---- |
Revaluation surplus | 87.44%-15.93M | ---- | -549.44%-19.56M | ---- | -169.74%-126.9M | ---- | -92.65%4.35M | ---- | 15.83%181.96M | ---- |
-Changes in the fair value of other assets | 87.44%-15.93M | ---- | -549.44%-19.56M | ---- | -169.74%-126.9M | ---- | -92.65%4.35M | ---- | 15.83%181.96M | ---- |
Impairment and provision | -23.24%-488.36M | -47.84%-377M | -13.68%-121.77M | -78.03%-794M | -30.63%-396.28M | -16.44%-255M | -2.42%-107.12M | 40.21%-446M | 40.90%-303.36M | 49.42%-219M |
-Other impairment is provision | -23.24%-488.36M | -47.84%-377M | -13.68%-121.77M | -78.03%-794M | -30.63%-396.28M | -16.44%-255M | -2.42%-107.12M | 40.21%-446M | 40.90%-303.36M | 49.42%-219M |
Special items of operating profit | -5.10%492.88M | 541.38%930M | -33.43%130.76M | -4.79%935M | -23.20%519.39M | -79.05%145M | -48.13%196.44M | -30.50%982M | -27.26%676.31M | 7.45%692M |
Operating profit | 20.93%3.85B | 29.03%2.95B | 15.81%1.22B | 84.20%3.84B | 59.09%3.18B | 26.91%2.29B | 3.55%1.06B | -71.07%2.08B | -69.79%2B | -68.46%1.8B |
Financing income | ---- | -36.00%320M | ---- | -5.33%284M | ---- | 122.22%500M | ---- | 4,900.00%300M | ---- | 389.13%225M |
Financing cost | -98.22%2.58M | -16.45%-439M | 56.60%-53.78M | ---- | -73.51%144.97M | ---377M | -2,247.08%-123.92M | ---- | 1,043.85%547.36M | ---- |
Share of profits of associates | ---- | -66.67%25M | ---- | 17.69%153M | ---- | 10.29%75M | ---- | -15.58%130M | ---- | -29.90%68M |
Special items of earning before tax | -14.61%41.66M | ---- | -43.22%6.64M | ---- | -15.72%48.79M | ---- | -23.70%11.7M | ---- | -29.54%57.89M | ---- |
Earning before tax | 15.30%3.89B | 14.97%2.86B | 24.59%1.18B | 70.06%4.27B | 29.57%3.38B | 18.62%2.49B | -9.32%944.45M | -65.86%2.51B | -61.41%2.61B | -64.22%2.1B |
Tax | -27.69%-399.29M | -29.32%-322M | -82.23%-156.16M | -431.40%-457M | 19.65%-312.7M | 21.20%-249M | 18.76%-85.7M | 90.83%-86M | 58.44%-389.17M | 65.31%-316M |
After-tax profit from continuing operations | 14.03%3.49B | 13.37%2.54B | 18.83%1.02B | 57.25%3.82B | 38.21%3.06B | 25.69%2.24B | -8.26%858.75M | -62.21%2.43B | -61.88%2.22B | -64.02%1.78B |
Earning after tax | 14.03%3.49B | 13.37%2.54B | 18.83%1.02B | 57.25%3.82B | 38.21%3.06B | 25.69%2.24B | -8.26%858.75M | -62.21%2.43B | -61.88%2.22B | -64.02%1.78B |
Minority profit | 70.20%353.34M | 41.11%254M | 114.97%104.66M | 235.44%265M | 338.71%207.6M | 318.60%180M | 63.99%48.69M | -31.90%79M | -25.07%47.32M | -37.68%43M |
Profit attributable to shareholders | 9.95%3.14B | 10.94%2.28B | 13.06%915.82M | 51.26%3.55B | 31.65%2.86B | 18.43%2.06B | -10.63%810.06M | -62.76%2.35B | -62.29%2.17B | -64.40%1.74B |
Basic earnings per share | 11.76%0.38 | 10.78%0.2764 | 10.00%0.11 | 54.86%0.4305 | 36.00%0.34 | 21.95%0.2495 | -9.09%0.1 | -63.31%0.278 | -64.29%0.25 | -65.71%0.2046 |
Diluted earnings per share | 8.82%0.37 | 9.55%0.2708 | 10.00%0.11 | 54.80%0.4285 | 36.00%0.34 | 21.89%0.2472 | -9.09%0.1 | -63.24%0.2768 | -64.29%0.25 | -65.56%0.2028 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data